In summary, we show that SIRT3 regulates hepatic levels of MTP by modulating its acetylation status, which in turn leads to regulation of mitochondrial FAO, impacting development and rescue of NAFLD. The gene discussed is SIRT3; the disease is metabolic dysfunction-associated steatotic liver disease.